Quintiles named a new chief medical and scientific officer this morning.
Jeffrey A. Spaeder, 43, succeeds Oren Cohen, who now leads the Durham company's Phase I clinical research business.
Spaeder is a cardiologist with a medical degree from Johns Hopkins. He recently was executive director of global medical affairs Takeda Pharmaceuticals.
Quintiles is the world's largest provider of services to pharmaceutical and biotechnology companies. It employs about 20,000 people worldwide, including 1,600 in the Triangle.
In his new role, Spaeder will oversee Quintiles' drug safety and ethical conduct in clinical drug testing.